<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Dainippon Pharmaceuticals USA Corporation from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Dainippon Pharmaceuticals USA Corporation news from BioPortfolio.com</description>
	<pubDate>Tue, 09 Feb 2010 23:05:03 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Dainippon+Pharmaceuticals+USA+Corporation" rel="self" type="application/rss+xml" />

	
<item><title>Alnylam and Collaborators Discover Additional Class of Novel Lipid Nanoparticles with Markedly Improved In Viv</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3954986&amp;HITNO=0&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3954986&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2493483171%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3954986&amp;HITNO=0&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3954986&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2493483171%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>Alnylam, collaborators discover additional class of novel lipid nanoparticles with markedly improved in vivo p</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3941112&amp;HITNO=1&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3941112&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2485332619%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3941112&amp;HITNO=1&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3941112&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2485332619%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PharmaBiz:</description></item>
<item><title>New LNP compositions that improve systemic delivery of RNAi therapeutics discovered</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3934146&amp;HITNO=2&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3934146&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2482074095%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3934146&amp;HITNO=2&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3934146&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2482074095%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>News-Medical.Net:</description></item>
<item><title>Alnylam Pharma (ALNY) Announces Publication of LNP Systemic Delivery Data Publication</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3928630&amp;HITNO=3&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3928630&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479281645%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3928630&amp;HITNO=3&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3928630&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479281645%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>Alnylam and Collaborators Discover Additional Class of Novel Lipid Nanoparticles with Markedly Improved In Viv</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3928135&amp;HITNO=4&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3928135&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479137674%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3928135&amp;HITNO=4&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3928135&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479137674%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>Alnylam and Collaborators Discover Additional Class of Novel Lipid Nanoparticles with Markedly Improved In Vivo Potency for RNAi Therapeutics</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3927925&amp;HITNO=5&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3927925&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479063193%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3927925&amp;HITNO=5&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3927925&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479063193%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>New Paper Published in Nature Biotechnology Reports on a Rational Design Approach for Discovery of Novel Lipid Nanoparticles</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3927869&amp;HITNO=6&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3927869&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479055517%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3927869&amp;HITNO=6&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3927869&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479055517%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Azonano:</description></item>
<item><title>New Paper Published in Nature Biotechnology Reports on a Rational Design Approach for Discovery of Novel Lipids New Paper Published in Nature Biotechnology Reports on a Rational Design Approach for Di</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3927757&amp;HITNO=7&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3927757&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479017132%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3927757&amp;HITNO=7&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3927757&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479017132%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Azonano:</description></item>
<item><title>Altea Therapeutics and KAI Pharmaceuticals Enter into a Preclinical and Clinical Development ...</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3911595&amp;HITNO=8&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3911595&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2469732187%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3911595&amp;HITNO=8&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3911595&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2469732187%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PipelineReview:</description></item>
<item><title>2010 Facility of the Year Awards (FOYA) Winners Announced</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3915142&amp;HITNO=9&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3915142&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2471277529%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3915142&amp;HITNO=9&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3915142&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2471277529%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PR-USA.net:</description></item>
<item><title>2010 Facility of the Year Awards (FOYA) Winners Announced</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3891595&amp;HITNO=10&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3891595&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2459793233%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3891595&amp;HITNO=10&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3891595&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2459793233%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PharmaceuticalProcessing:</description></item>
<item><title>2010 Facility of the Year Awards (FOYA) Winners Announced</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3890082&amp;HITNO=11&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3890082&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2459032944%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3890082&amp;HITNO=11&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3890082&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2459032944%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>Dainippon Sumitomo Pharma America Announces the NDA Submission of Lurasidone to the FDA for the Treatment of S</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3854989&amp;HITNO=12&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3854989&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2441684453%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3854989&amp;HITNO=12&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3854989&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2441684453%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PR Newswire:</description></item>
<item><title>Stocks Showing Unusually Heavy Volume - Achillion Pharmaceuticals Inc, AAR Corp, Delta Petroleum Corp, deCODE</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3798394&amp;HITNO=13&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3798394&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2408289280%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3798394&amp;HITNO=13&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3798394&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2408289280%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Schaeffers Research:</description></item>
<item><title>Elan Drug gets Japanese nod for product using NanoCrystal technology</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3791039&amp;HITNO=14&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3791039&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2405133734%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3791039&amp;HITNO=14&amp;MSIZE=20&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Dainippon%20Pharmaceuticals%20USA%20Corporation&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3791039&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2405133734%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PharmaBiz:</description></item>
</channel></rss>